Literature DB >> 11807179

The binding site of aminergic G protein-coupled receptors: the transmembrane segments and second extracellular loop.

Lei Shi1, Jonathan A Javitch.   

Abstract

In the current chapter, we review approaches to the identification of the residues forming the binding sites for agonists, antagonists, and allosteric modulators in the family of aminergic G protein-coupled receptors (GPCRs). We then review the structural bases for ligand binding and pharmacological specificity based on the application of these methods to muscarinic cholinergic, adrenergic, dopaminergic, serotonergic, and histaminergic receptors, using the high resolution rhodopsin structure as a template. Furthermore, we propose a critical role of the second extracellular loop in forming the binding site for small molecular weight aminergic ligands, much as this loop dives down into the binding-site crevice and contacts retinal in rhodopsin.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11807179     DOI: 10.1146/annurev.pharmtox.42.091101.144224

Source DB:  PubMed          Journal:  Annu Rev Pharmacol Toxicol        ISSN: 0362-1642            Impact factor:   13.820


  95 in total

Review 1.  Sequence analyses of G-protein-coupled receptors: similarities to rhodopsin.

Authors:  Tara Mirzadegan; Gil Benkö; Sławomir Filipek; Krzysztof Palczewski
Journal:  Biochemistry       Date:  2003-03-18       Impact factor: 3.162

2.  Predicting flexible loop regions that interact with ligands: the challenge of accurate scoring.

Authors:  Matthew L Danielson; Markus A Lill
Journal:  Proteins       Date:  2011-11-09

3.  Prediction of the odorant binding site of olfactory receptor proteins by human-mouse comparisons.

Authors:  Orna Man; Yoav Gilad; Doron Lancet
Journal:  Protein Sci       Date:  2004-01       Impact factor: 6.725

4.  Key issues in the computational simulation of GPCR function: representation of loop domains.

Authors:  E L Mehler; X Periole; S A Hassan; H Weinstein
Journal:  J Comput Aided Mol Des       Date:  2002-11       Impact factor: 3.686

5.  G protein-coupled receptors: in silico drug discovery in 3D.

Authors:  Oren M Becker; Yael Marantz; Sharon Shacham; Boaz Inbal; Alexander Heifetz; Ori Kalid; Shay Bar-Haim; Dora Warshaviak; Merav Fichman; Silvia Noiman
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-26       Impact factor: 11.205

6.  Receptor conformations involved in dopamine D(2L) receptor functional selectivity induced by selected transmembrane-5 serine mutations.

Authors:  J Corey Fowler; Supriyo Bhattacharya; Jonathan D Urban; Nagarajan Vaidehi; Richard B Mailman
Journal:  Mol Pharmacol       Date:  2012-03-13       Impact factor: 4.436

7.  GPCRRD: G protein-coupled receptor spatial restraint database for 3D structure modeling and function annotation.

Authors:  Jian Zhang; Yang Zhang
Journal:  Bioinformatics       Date:  2010-10-05       Impact factor: 6.937

8.  Crystal structure-based virtual screening for fragment-like ligands of the human histamine H(1) receptor.

Authors:  Chris de Graaf; Albert J Kooistra; Henry F Vischer; Vsevolod Katritch; Martien Kuijer; Mitsunori Shiroishi; So Iwata; Tatsuro Shimamura; Raymond C Stevens; Iwan J P de Esch; Rob Leurs
Journal:  J Med Chem       Date:  2011-11-07       Impact factor: 7.446

9.  Point mutations in the second extracellular loop of the histamine H2 receptor do not affect the species-selective activity of guanidine-type agonists.

Authors:  Hendrik Preuss; Prasanta Ghorai; Anja Kraus; Stefan Dove; Armin Buschauer; Roland Seifert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-11-13       Impact factor: 3.000

10.  The role of a sodium ion binding site in the allosteric modulation of the A(2A) adenosine G protein-coupled receptor.

Authors:  Hugo Gutiérrez-de-Terán; Arnault Massink; David Rodríguez; Wei Liu; Gye Won Han; Jeremiah S Joseph; Ilia Katritch; Laura H Heitman; Lizi Xia; Adriaan P Ijzerman; Vadim Cherezov; Vsevolod Katritch; Raymond C Stevens
Journal:  Structure       Date:  2013-11-07       Impact factor: 5.006

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.